English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 19, 2025

Patients Rising CEO on 340B reform: ‘Patients aren’t seeing the discounts — everyone is just paying more downstream’
+ Pharmaceuticals
Patient Daily | Nov 19, 2025

American Lung Association highlights free lung health navigator program for World COPD Day
+ Pharmaceuticals
Patient Daily | Nov 19, 2025

Precautions advised by allergists for managing holiday allergy and asthma triggers
+ Pharmaceuticals
Patient Daily | Nov 19, 2025

Dauten family donates $25 million for new Northwestern Medicine Behavioral Health Institute
+ Pharmaceuticals
Patient Daily | Nov 18, 2025

Pacific Research Institute CEO: 340B misuse is 'reducing competition, narrowing patient choices, and driving costs up'
+ Pharmaceuticals
Patient Daily | Nov 18, 2025

Tips from Baylor psychiatrist on handling political talk during holidays
+ Community
Patient Daily | Nov 18, 2025

Westerly Hospital buries time capsule marking centennial for opening in 2075
+ Pharmaceuticals
Patient Daily | Nov 17, 2025

Baylor College of Medicine doctors warn about risks of air pollution on lung health

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns